Current Report Filing (8-k)
May 09 2019 - 4:53PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 7, 2019
ContraFect Corporation
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-36577
|
|
39-2072586
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification Number)
|
28 Wells Avenue, 3rd Floor, Yonkers, New York 10701
(Address of principal executive offices) (Zip Code)
(914)
207-2300
Registrants telephone number, including area code
N/A
(Former Name or
Former Address, if Changed Since Last Report)
Check the appropriate box below
if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
|
☐
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
|
|
☐
|
|
Soliciting material pursuant to Rule
14a-12
under the
Exchange Act (17 CFR
240.14a-12)
|
|
|
|
☐
|
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
|
|
|
☐
|
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company ☒
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ☒
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Common Stock,
$0.0001 par value per
share
|
|
CFRX
|
|
Nasdaq Capital Market
|
Item 5.07. Submission of Matters to a Vote of Security Holders.
On May 7, 2019, ContraFect Corporation (the Company) held its Annual Meeting of Stockholders. A total of 55,966,926 shares of common stock
were present in person or represented by proxy at the meeting, representing approximately 70.5% percent of the Companys outstanding common stock as of the March 11, 2019 record date. The following are the voting results for the proposals
considered and voted upon at the meeting, each of which were described in the Companys Definitive Proxy Statement filed with the Securities and Exchange Commission on March 20, 2019.
Item 1 Election of seven directors for a term of office expiring on the date of the annual meeting of stockholders in 2020 and until their respective
successors have been duly elected and qualified.
|
|
|
|
|
|
|
|
|
|
|
|
|
NOMINEE
|
|
Votes FOR
|
|
|
Votes
WITHHELD
|
|
|
Broker Non-Votes
|
|
Sol J. Barer, Ph.D.
|
|
|
30,409,712
|
|
|
|
668,456
|
|
|
|
24,888,758
|
|
Isaac Blech
|
|
|
18,038,062
|
|
|
|
13,040,106
|
|
|
|
24,888,758
|
|
Steven C. Gilman, Ph.D.
|
|
|
26,741,548
|
|
|
|
4,336,620
|
|
|
|
24,888,758
|
|
David N. Low, Jr., M.B.A.
|
|
|
30,517,075
|
|
|
|
561,093
|
|
|
|
24,888,758
|
|
Michael J. Otto, Ph.D.
|
|
|
30,590,834
|
|
|
|
487,334
|
|
|
|
24,888,758
|
|
Roger J. Pomerantz, M.D., F.A.C.P.
|
|
|
30,541,363
|
|
|
|
536,805
|
|
|
|
24,888,758
|
|
Cary W. Sucoff, J.D.
|
|
|
24,969,831
|
|
|
|
6,108,336
|
|
|
|
24,888,758
|
|
Item 2 Ratification of the appointment of Ernst & Young LLP as the Companys independent registered
public accounting firm for the year ending December 31, 2019.
|
|
|
|
|
|
|
Votes FOR
|
|
Votes AGAINST
|
|
Votes ABSTAINED
|
|
Broker Non-Votes
|
55,443,492
|
|
122,182
|
|
401,252
|
|
0
|
Based on the foregoing votes, the seven director nominees were elected and Item 2 was approved.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
CONTRAFECT CORPORATION
|
|
|
|
|
Date: May 9, 2019
|
|
|
|
By:
|
|
/s/ Natalie Bogdanos
|
|
|
|
|
|
|
Natalie Bogdanos
|
|
|
|
|
|
|
General Counsel and Corporate Secretary
|
ContraFect (NASDAQ:CFRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
ContraFect (NASDAQ:CFRX)
Historical Stock Chart
From Apr 2023 to Apr 2024